Next Touch: BridGene Biosciences $28M Pipeline Trigger
BridGene just closed $28M Series B. Ping Cao needs chemoproteomics & clinical ops scale. Grab this battle card for your next touch and fill your pipeline fast.
Published on
Do not index
Do not index
๐ Battle Card: BridGene Biosciences
Quick trigger:
ย
๐ค Decision Maker in the News
- Ping Cao, Ph.D., Co-Founder & CEO ๐ง ping.cao@bridgenebio.com
ย
๐ก Why It Matters
- This funding supercharges BGC-515 clinical development and scales IMTACโข screening for next-gen small molecules. โ Source
ย
๐ฏ Core Pain Point
- Data bottlenecks in chemoproteomics delay candidate ID
- Budget pressures for scaling clinical and R&D ops
ย
๐ฐ What to Pitch
- Primary: Integrated chemoproteomics informatics platform โ accelerates binding site discovery by 30%
- Expansion: Clinical development management solution โ streamlines multicenter trial workflows
ย
๐บ๏ธ Quick Context
- HQ: San Jose, CA
- Employees: โ 75
- Rev: โ $3M
- Website: https://www.bridgenebio.com
ย
๐คผ Competitive Intel
Which other vendors youโll probably face to win BridGene Biosciencesโs business.
ย
- Benchling โ R&D Cloud Platform
- Unique edge: Unified LIMS & ELN for bio teams
- Evaluated by Head of R&D for collaboration
- benchling.com
- Dotmatics โ Scientific Informatics
- Unique edge: Comprehensive chemistry & biology data management
- Evaluated by CSO for platform depth
- dotmatics.com
- Veeva Systems โ Clinical Trial Management
- Unique edge: Compliance-focused CTMS
- Evaluated by Head of Clinical Ops for trial readiness
- veeva.com
ย
โ Do-Now Checklist
Connect with Ping Cao on email to discuss the BridGene Biosciences sales trigger
Generate email + DM using the BridGene Biosciences sales trigger to showcase streamlined workflows
Schedule follow-ups in CRM (Day 3 & Day 10)
ย
Next Step
Get BridGene Biosciences sales trigger intel like this dailyโno fluff, all pipeline.
Subscribe to NewsletterForLeads
ย
๐ง Copy My Prompt for Personalized Cold Outreach
โโโโโโโโโโโโโโโโโโโโโโโโโโโโ
โ๏ธ YOUR COMPANY
โโโโโโโโโโโโโโโโโโโโโโโโโโโโ
OUR_COMPANY = โ<your company>โ
OFFER_BRIEF = โIntegrated chemoproteomics informatics platformโ
PROOF_METRIC = โaccelerates binding site discovery by 30%โ
CTA_STYLE = โquick_callโ
TONE = โfriendlyโ
โโโโโโโโโโโโโโโโโโโโโโโโโโโโ
๐ TARGET COMPANY
โโโโโโโโโโโโโโโโโโโโโโโโโโโโ
NAME = Ping
COMPANY = BridGene Biosciences
DEPT = R&D
SIZE = 75
BOTTLENECK = data bottlenecks in chemoproteomics delay candidate ID
EVENT = $28M Series B+ financing round
DETAIL = $28M Series B+ financing
PAIN = Data bottlenecks in chemoproteomics delay candidate ID
SRC = https://vcnewsdaily.com/bridgene-biosciences/venture-capital-funding/zgjhqmkphm
SIM_CO = Benchling
WIN_METRIC = accelerated binding site discovery by 30%
NEXT_SIZE = 150
EMP_EST = โ 75
REV_EST = โ $3M
โโโโโโโโโโโโโโโโโโโโโโโโ
TASK FOR CHATGPT
โโโโโโโโโโโโโโโโโโโโโโโโ
Role: โNewsletterForLeads SDR-Assistโ.
Validate any โ guesses via SRC.
EMAIL (keep breaks):
Subject: 75-person R&D
Pingโnoticed your R&D team is โ 75.
Thatโs when data bottlenecks in chemoproteomics delay candidate ID slows growth.
We helped Benchling fix this with Integrated chemoproteomics informatics platform.
Result: accelerated binding site discovery by 30%.
Quick call?
PSโnext bottleneck hits โ 150.
DM โค45 words, TONE:
Saw your post about $28M Series B+ financing โ Data bottlenecks in chemoproteomics delay candidate ID.
Integrated chemoproteomics informatics platform. accelerates binding site discovery by 30%.
Quick chat?